Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Osteosarcoma × dinutuximab × Clear all

Phase

Status

Sponsor Class

NIH 2 OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Neuroblastoma 13 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Osteosarcoma 1 Neoplasms 1 Neoplasm, Residual 1 Leiomyosarcoma 1 Ganglioneuroblastoma 1 Bone Neoplasms 1

Interventions

Ifosfamide 20 Methotrexate 19 Cyclophosphamide 18 Doxorubicin 16 Cisplatin 13 Gemcitabine 10 Filgrastim 10 Etoposide 10 Leucovorin 8 fludarabine 7 apatinib 7 Radiotherapy 6 Nivolumab 6 Neoadjuvant Therapy 6 Drug Therapy 6 Zoledronic Acid 5 Vincristine 5 Temozolomide 5 Mesna 5 Irinotecan 5 Granulocyte Colony-Stimulating Factor 5 Docetaxel 5 Carboplatin 5 regorafenib 4 pegfilgrastim 4 glucarpidase 4 cabozantinib 4 Topotecan 4 Surveys and Questionnaires 4 Sunitinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05400603 2025-12-26

Aflac-NBL-2002

Emory University

Phase 1 Recruiting

Neuroblastoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡